Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 43, Issue 1, 1998, Pages 69-74

  Homesley, Howard D ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Carolina Gynecologic Oncology   (United States)

Author keywords

Actinomycin D; Methotrexate; Trophoblastic tumor

Indexed keywords

DACTINOMYCIN; METHOTREXATE;

CANCER CHEMOTHERAPY; CANCER REGRESSION; CONFERENCE PAPER; DISEASE COURSE; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY; TROPHOBLASTIC DISEASE;

EID: 0031884103     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Ayhan A, Tuncer ZS, Halilzade H, Kucukali T: Predictors of persistent disease in women with complete hydatidiform mole. J Reprod Med 1996;41:591-594
2. Berkowitz RS, Goldstein DP: Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms. Obstet Gynecol 1979;54:725-728
3. Elit L, Covens A, Osborne R, et al: High-dose methotrexate for gestational trophoblastic disease. Gynecol Oncol 1994;54:282-287
4. Gillespie AM, Lorigan PC, Coleman J, et al: The role of second surgical uterine evacuation in gestational trophoblastic disease (abstr). Proc of the VIIIth World Congress on Gestational Trophoblastic Diseases, Seoul, November 1996
5. Hammond CB, Hertz R, Ross GT, et al: Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasms. Am J Obstet Gynecol 1967;98:71-78
6. Hoffman MS, Fiorica JV, Gleeson NC, et al: A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Gynecol Oncol 1996;60:292-294
7. Homesley HD: Development of single-agent chemotherapy regimens for gestational trophoblastic disease. J Reprod Med 1996;39:185-192
8. Homesley HD, Blessing JA, Rettenmaier M, et al: Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Obstet Gynecol 1988;72:413-418
9. Homesley HD, Blessing JA, Schlaerth J, et al: Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: A Gynecologic Oncology Group study. Gynecol Oncol 1990;39:305-308
10. Kohorn EI: Decision making for chemotherapy administration in patients with low risk gestational trophoblastic neoplasia. Int J Gynecol Oncol 1996;6:279-284
11. Kohorn EI: Evaluation of criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia. Gynecol Oncol 1993;48:136-147
12. Mangili G, Garavaglia E, Frigerio L, et al: Management of low risk gestational trophoblastic tumors with etoposide (VP-16) in patients resistant to methotrexate. Gynecol Oncol 1996;61:218-220
13. Mutch D, Soper JT, Baker M, et al: Role of computed axial tomography of the chest in staging patients with nonmetastatic gestational trophoblastic disease. Obstet Gynecol 1986;68: 348-352
14. Newlands ES, Rustin GJS, Lutz J-M, et al: Chemotherapy for gestational trophoblastic tumours (GTT) may increase the incidence of second rumours and may cause a premature menopause (abstr). Proc of the 32nd annual meeting of the American Society of Clinical Oncologists, Philadelphia, May 18-21, 1996
15. Ngan H, Chan F, Cheng P, et al: Clinical outcome or micrometastases in the lung in stage 1A persistent trophoblastic disease (abstr). Proc of the VIIIth World Congress on Gestational Trophoblastic Disease, Seoul, November 1996
16. Osborne, RJ, Gerulath A: A comparison of weekly methotrexate "pulse" actinomycin-D and the "Bagshawe" regimen in the treatment of low risk persistent GTD (abstr). Proc of the VIIIth World Congress on Gestational Diseases, Seoul, November 1996
17. Petrilli ES, Twiggs LB, Blessing JA, et al: Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease: A prospective Phase II trial of the Gynecologic Oncology Group. Cancer 1987;60:2173-2176
18. Roberts JP, Lurain JR: Treatment of low risk metastatic gestational trophoblastic tumors with single agent chemotherapy. Am J Obstet Gynecol 1996;174:1917-1926
19. Rose PG, Piver MS: Alternating methotrexate and dactinomycin in nonmetastatic gestational trophoblastic disease. J Surg Oncol 1989;41:148-152
20. Rustin GJ, Newlands ES, Lutz JM, et al: Combination but not single agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol 1996;14:2769-2773
21. Shigematsu T, Saito T, Kamura T, et al: Usefulness of a spontaneous regression curve of human chorionic gonadotropin after evacuation of molar pregnancy (abstr). Proc of the VIIIth World Congress on Gestational Trophoblastic Diseases, Seoul, November 1996
22. Sung HC, Wu PC, Yang HY: Re-evaluation of 5-fluorouracil as a single therapeutic agent for gestational trophoblastic neoplasms. Am J Obstet Gynecol 1984;150:69-75
23. Womack C, Elston CW: Hydatidiform mole in Nottingham: A 12 year retrospective epidemiological and morphological study. Placenta 1985;6:93-105
24. Wong LC, Choo YC, Ma HK: Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. Am J Obstet Gynecol 1985;152:59-62
25. Yedema KA, Verheijen RH, Kenemans P, et al: Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve. Am J Obstet Gynecol 1993;168:787-792
26. Zanetta G, Lissoni A, Colombo M, et al: Detection of abnormal intrauterine vascularization by color Doppler imaging: A possible additional aid for the follow-up of patients with gestational trophoblastic tumors. Ultrasound Obstet Gynecol 1996;7:32-37